{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:08:02Z","timestamp":1777900082448,"version":"3.51.4"},"reference-count":37,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Cytomegalovirus (CMV) establishes lifelong latency following primary infection and can reactivate to cause severe illness in immunocompromised hosts. CMV DNAemia in non-HIV-infected, non-solid organ\/bone marrow transplant (NHNT) hosts is poorly characterized, with limited clinical insights. We aim to describe the clinical presentation, prognostic indicators, and outcomes of CMV DNAemia among NHNT patients. We used the TriNetX international patient database to identify adult patients diagnosed with CMV DNAemia from 2016 until March 2023. We evaluated hospitalization, intensive care unit (ICU) level care, and all-cause mortality at 30 days and 1 year. We also completed a post-propensity score analysis comparing clinical characteristics of survivors versus non-survivors at 90 days. We identified 1123 NHNT patients with CMV DNAemia, most of whom had neoplasms (63%). Venous thromboembolism occurred in 31% of the population. The 30-day hospitalization and all-cause mortality rates were 35% and 14%, respectively. After propensity score matching and Bonferroni correction, weakness, purpura, acute respiratory failure, malnutrition, encephalopathy, and hypotension were associated with increased 90-day all-cause mortality. NHNT patients with CMV DNAemia carry a substantial morbidity and all-cause mortality. Further studies are warranted to clarify whether CMV DNAemia is a causative factor or an incidental finding in this population.<\/jats:p>","DOI":"10.3390\/pathogens15050492","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:15:27Z","timestamp":1777630527000},"page":"492","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Characteristics and Outcomes of Cytomegalovirus DNAemia in Non-HIV-Infected and Non-Transplant Patients: A Propensity Score-Matched Analysis"],"prefix":"10.3390","volume":"15","author":[{"given":"Ixchel","family":"Salter","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, University of Colorado Denver, Aurora, CO 80045, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaele-Francesco","family":"Corbisiero","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, University of Colorado Denver, Aurora, CO 80045, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4018-0195","authenticated-orcid":false,"given":"Daniel B.","family":"Chastain","sequence":"additional","affiliation":[{"name":"Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Albany, GA 31701, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5241-3435","authenticated-orcid":false,"given":"Chia-Yu","family":"Chiu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, University of Colorado Denver, Aurora, CO 80045, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1392-3475","authenticated-orcid":false,"given":"Leland","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, University of Colorado Denver, Aurora, CO 80045, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose G.","family":"Montoya","sequence":"additional","affiliation":[{"name":"Dr. Jack S. Remington Laboratory for Specialty Diagnostics, Palo Alto, CA 94301, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymund R.","family":"Razonable","sequence":"additional","affiliation":[{"name":"Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7363-8652","authenticated-orcid":false,"given":"Andr\u00e9s F.","family":"Henao-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, University of Colorado Denver, Aurora, CO 80045, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"ref_1","first-page":"519","article-title":"Cytomegalovirus","volume":"67","author":"Taylor","year":"2003","journal-title":"Am. Fam. Physician"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Al Mana, H., Yassine, H.M., Younes, N.N., Al-Mohannadi, A., Al-Sadeq, D.W., Alhababi, D., Nasser, E.A., and Nasrallah, G.K. (2019). The Current Status of Cytomegalovirus (CMV) Prevalence in the MENA Region: A Systematic Review. Pathogens, 8.","DOI":"10.3390\/pathogens8040213"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00134-024-07737-5","article-title":"What Intensivists Need to Know about Cytomegalovirus Infection in Immunocompromised ICU Patients","volume":"51","author":"Castro","year":"2025","journal-title":"Intensive Care Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s13054-024-05029-4","article-title":"Clinical Characteristics and Outcomes of Immunocompromised Critically Ill Patients with Cytomegalovirus End-Organ Disease: A Multicenter Retrospective Cohort Study","volume":"28","author":"Grafia","year":"2024","journal-title":"Crit. Care"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Park, G.E., Ki, H.K., and Ko, J.-H. (2021). Impact of Antiviral Treatment on Long-Term Prognosis in Non-Immunocompromised Patients with CMV Reactivation. BMC Infect. Dis., 21.","DOI":"10.1186\/s12879-021-06098-4"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.cmi.2022.05.034","article-title":"Comparative Clinical Manifestations and Immune Effects of Cytomegalovirus Infections Following Distinct Types of Immunosuppression","volume":"28","author":"Ong","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"20926","DOI":"10.1038\/s41598-022-25451-4","article-title":"Risk Factors Associated with Cytomegalovirus Reactivation in Patients Receiving Immunosuppressive Therapy for Rheumatic Diseases: A Retrospective Study","volume":"12","author":"Shimada","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1016\/S1473-3099(19)30107-0","article-title":"Guidelines for the Management of Cytomegalovirus Infection in Patients with Haematological Malignancies and after Stem Cell Transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)","volume":"19","author":"Ljungman","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1016\/S1473-3099(25)00069-6","article-title":"Recommendations from the 10th European Conference on Infections in Leukaemia for the Management of Cytomegalovirus in Patients after Allogeneic Haematopoietic Cell Transplantation and Other T-Cell-Engaging Therapies","volume":"25","author":"Ljungman","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jcrc.2014.10.002","article-title":"Cytomegalovirus Reactivation in a General, Nonimmunosuppressed Intensive Care Unit Population: Incidence, Risk Factors, Associations with Organ Dysfunction, and Inflammatory Biomarkers","volume":"30","author":"Frantzeskaki","year":"2015","journal-title":"J. Crit. Care"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"116967","DOI":"10.1016\/j.diagmicrobio.2025.116967","article-title":"Cytomegalovirus Reactivation among Immunocompetent Patients Hospitalized in Medical Intensive Care: Associated Factors and Consequences","volume":"113","author":"Zouaki","year":"2025","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jama.2008.697","article-title":"Cytomegalovirus Reactivation in Critically Ill Immunocompetent Patients","volume":"300","author":"Limaye","year":"2008","journal-title":"JAMA"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Schildermans, J., and De Vlieger, G. (2020). Cytomegalovirus: A Troll in the ICU? Overview of the Literature and Perspectives for the Future. Front. Med., 7.","DOI":"10.3389\/fmed.2020.00188"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/acel.12059","article-title":"Cytomegalovirus Infection Is Associated with Increased Mortality in the Older Population","volume":"12","author":"Savva","year":"2013","journal-title":"Aging Cell"},{"key":"ref_15","first-page":"20499361231159481","article-title":"Previous Corticosteroid Exposure Associates with an Increased Pneumocystis Jirovecii Pneumonia Mortality among HIV-Negative Patients: A Global Research Network with a Follow-up Multicenter Case-Control Study","volume":"10","author":"Molina","year":"2023","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"ofae115","DOI":"10.1093\/ofid\/ofae115","article-title":"Risk of Invasive Fungal Infections in Patients with Chronic Lymphocytic Leukemia Treated with Bruton Tyrosine Kinase Inhibitors: A Case-Control Propensity Score-Matched Analysis","volume":"11","author":"Chastain","year":"2024","journal-title":"Open Forum Infect. Dis."},{"key":"ref_17","unstructured":"National Institutes of Health, Centers for Disease Control and Prevention, and HIV Medicine Association of the Infectious Diseases Society of America Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV\u2014A Working Group of the Office of AIDS Research Advisory Council (OARAC) (2026). Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. ClinicalInfo.HIV.gov [Internet], US Department of Health and Human Services."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/jcp.45.11.1037","article-title":"Severe Thrombocytopenia Secondary to Asymptomatic Cytomegalovirus Infection in an Immunocompetent Host","volume":"45","author":"Wright","year":"1992","journal-title":"J. Clin. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Flores-Chang, B.S., Arias-Morales, C.E., Wadskier, F.G., Gupta, S., and Stoicea, N. (2015). Immune Thrombocytopenic Purpura Secondary to Cytomegalovirus Infection: A Case Report. Front. Med., 2.","DOI":"10.3389\/fmed.2015.00079"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1365-2141.2009.07714.x","article-title":"Cytomegalovirus Can Make Immune Thrombocytopenic Purpura Refractory","volume":"146","author":"DiMaggio","year":"2009","journal-title":"Br. J. Haematol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"41840","DOI":"10.1038\/s41598-025-25791-x","article-title":"Risk Factors Associated with Cytomegalovirus Reactivation and Disease in Critically-Ill COVID-19 and Non-COVID-19 Patients, Concomitantly Admitted to Intensive Care","volume":"15","author":"Korem","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1111\/imj.15496","article-title":"Cytomegalovirus DNAemia and Disease: Current-Era Epidemiology, Clinical Characteristics and Outcomes in Cancer Patients Other than Allogeneic Haemopoietic Transplantation","volume":"52","author":"Tay","year":"2022","journal-title":"Intern. Med. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e0119124","DOI":"10.1128\/mbio.01191-24","article-title":"Human Cytomegalovirus UL23 Exploits PD-L1 Inhibitory Signaling Pathway to Evade T Cell-Mediated Cytotoxicity","volume":"15","author":"Yuan","year":"2024","journal-title":"mBio"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00705-025-06457-5","article-title":"NK and T Cell Evasion Mechanism of Human Cytomegalovirus","volume":"170","author":"Sarker","year":"2025","journal-title":"Arch. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"El Baba, R., and Herbein, G. (2021). Immune Landscape of CMV Infection in Cancer Patients: From \u201cCanonical\u201d Diseases Toward Virus-Elicited Oncomodulation. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.730765"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1128\/MMBR.00018-16","article-title":"Virion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: A Sticky Virus Makes a Slick Getaway","volume":"80","author":"Gardner","year":"2016","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Zhang, X., Wang, Q., Han, S., Song, G., Wang, B., and Wang, Y. (2025). Human Cytomegalovirus-IE2 Suppresses Antigen Presentation of Macrophage through the IL10\/STAT3 Signalling Pathway in Transgenic Mouse. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0322334"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"108231","DOI":"10.1016\/j.ijid.2025.108231","article-title":"Cytomegalovirus DNAemia in the Lower Respiratory Tract in Nontransplant Patients with Hematologic Malignancies","volume":"163","author":"Naumiuk","year":"2026","journal-title":"Int. J. Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Cao, Y., and Li, L. (2025). Long-Term Prognosis Following Cytomegalovirus Respiratory Infection in Immunocompromised and Immunocompetent Patients: A Retrospective Single-Centre Study. BMC Infect. Dis., 25.","DOI":"10.1186\/s12879-025-11162-4"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00277-013-1715-3","article-title":"Thrombosis Following Acute Cytomegalovirus Infection: A Community Prospective Study","volume":"92","author":"Paran","year":"2013","journal-title":"Ann. Hematol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10096-018-3185-y","article-title":"Risk Factors of Venous Thrombo-Embolism during Cytomegalovirus Infection in Immunocompetent Individuals. A Systematic Review","volume":"37","author":"Ceccarelli","year":"2018","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e9336","DOI":"10.1097\/MD.0000000000009336","article-title":"Venous Thromboembolism Related to Cytomegalovirus Infection: A Case Report and Literature Review","volume":"96","author":"Kelkar","year":"2017","journal-title":"Medicine"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00277-011-1334-9","article-title":"Cytomegalovirus Infection Is Associated with Venous Thromboembolism of Immunocompetent Adults--a Case-Control Study","volume":"91","author":"Schimanski","year":"2012","journal-title":"Ann. Hematol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1469-0691.2009.03022.x","article-title":"Venous Thrombosis in Immunocompetent Patients with Acute Cytomegalovirus Infection: A Complication That May Be Underestimated","volume":"16","author":"Abgueguen","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"E134","DOI":"10.1086\/374664","article-title":"Vascular Thrombosis and Acute Cytomegalovirus Infection in Immunocompetent Patients: Report of 2 Cases and Literature Review","volume":"36","author":"Abgueguen","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1039\/C3MT00347G","article-title":"Serum Ferritin Is an Important Inflammatory Disease Marker, as It Is Mainly a Leakage Product from Damaged Cells","volume":"6","author":"Kell","year":"2014","journal-title":"Metallomics"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Horner, E., Lord, J.M., and Hazeldine, J. (2023). The Immune Suppressive Properties of Damage Associated Molecular Patterns in the Setting of Sterile Traumatic Injury. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1239683"}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/15\/5\/492\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:22:53Z","timestamp":1777630973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/15\/5\/492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["pathogens15050492"],"URL":"https:\/\/doi.org\/10.3390\/pathogens15050492","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}